Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Pension (2022 - 2023)

Neuphoria Therapeutics (NEUP) has disclosed Pension for 2 consecutive years, with $14969.9 as the latest value for Q2 2023.

  • On a quarterly basis, Pension rose 99.81% to $14969.9 in Q2 2023 year-over-year; TTM through Jun 2023 was $14969.9, a 99.81% increase, with the full-year FY2023 number at $15083.2, up 101.32% from a year prior.
  • Pension was $14969.9 for Q2 2023 at Neuphoria Therapeutics, up from $7492.2 in the prior quarter.
  • In the past five years, Pension ranged from a high of $14969.9 in Q2 2023 to a low of $7492.2 in Q2 2022.